share_log

HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $18 Price Target

Benzinga Real-time News ·  Jan 31, 2023 11:42

HC Wainwright & Co. analyst Yi Chen reiterates First Wave BioPharma (NASDAQ:FWBI) with a Buy and maintains $18 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment